In the originally published version of this manuscript, the Wellcome Trust funding was omitted. The funding section should mention Wellcome Trust grant number 108907/Z/15/Z. This error has been corrected online.
. 2021 Nov 11;31(1):156. doi: 10.1093/hmg/ddab325
Corrigendum to: NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss
R Salazar-Silva
1, Vitor Lima Goes Dantas
1, Leandro Ucela Alves
1, Ana Carla Batissoco
1,2, Jeanne Oiticica
2, Elizabeth A Lawrence
3, Abdelwahab Kawafi
3, Yushi Yang
4,5,6, Fernanda Stávale Nicastro
7, Beatriz Caiuby Novaes
7, Chrissy Hammond
3, Erika Kague
1,3,2,✉, R C Mingroni-Netto
1,2,✉
R Salazar-Silva
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
Find articles by R Salazar-Silva
Vitor Lima Goes Dantas
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
Find articles by Vitor Lima Goes Dantas
Leandro Ucela Alves
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
Find articles by Leandro Ucela Alves
Ana Carla Batissoco
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
2
Laboratório de Otorrinolaringologia/LIM32 –Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo , 01246-903, São Paulo, Brazil
Find articles by Ana Carla Batissoco
Jeanne Oiticica
2
Laboratório de Otorrinolaringologia/LIM32 –Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo , 01246-903, São Paulo, Brazil
Find articles by Jeanne Oiticica
Elizabeth A Lawrence
3
School of Pharmacology, Physiology and Neuroscience, University of Bristol, Bristol, BS8 1TD, United Kingdom
Find articles by Elizabeth A Lawrence
Abdelwahab Kawafi
3
School of Pharmacology, Physiology and Neuroscience, University of Bristol, Bristol, BS8 1TD, United Kingdom
Find articles by Abdelwahab Kawafi
Yushi Yang
4
School of Physics, University of Bristol, Bristol, BS8 1TL, United Kingdom
5
Centre for Nanoscience and Quantum Information, University of Bristol, Bristol, BS8 1FD, United Kingdom
6
Bristol Centre for Functional Nanomaterials, University of Bristol, Bristol, BS8 1FD, United Kingdom
Find articles by Yushi Yang
Fernanda Stávale Nicastro
7
Divisão de Educação e Reabilitação dos Distúrbios da Comunicação da Pontifícia Universidade Católica de São Paulo, 04022-040, São Paulo, Brazil
Find articles by Fernanda Stávale Nicastro
Beatriz Caiuby Novaes
7
Divisão de Educação e Reabilitação dos Distúrbios da Comunicação da Pontifícia Universidade Católica de São Paulo, 04022-040, São Paulo, Brazil
Find articles by Beatriz Caiuby Novaes
Chrissy Hammond
3
School of Pharmacology, Physiology and Neuroscience, University of Bristol, Bristol, BS8 1TD, United Kingdom
Find articles by Chrissy Hammond
Erika Kague
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
3
School of Pharmacology, Physiology and Neuroscience, University of Bristol, Bristol, BS8 1TD, United Kingdom
Find articles by Erika Kague
R C Mingroni-Netto
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
Find articles by R C Mingroni-Netto
1
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
2
Laboratório de Otorrinolaringologia/LIM32 –Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo , 01246-903, São Paulo, Brazil
3
School of Pharmacology, Physiology and Neuroscience, University of Bristol, Bristol, BS8 1TD, United Kingdom
4
School of Physics, University of Bristol, Bristol, BS8 1TL, United Kingdom
5
Centre for Nanoscience and Quantum Information, University of Bristol, Bristol, BS8 1FD, United Kingdom
6
Bristol Centre for Functional Nanomaterials, University of Bristol, Bristol, BS8 1FD, United Kingdom
7
Divisão de Educação e Reabilitação dos Distúrbios da Comunicação da Pontifícia Universidade Católica de São Paulo, 04022-040, São Paulo, Brazil
✉
Corresponding authors: R.C. Mingroni-Netto (renetto@ib.usp.br) and Erika Kague (erika.kague@bristol.ac.uk)
2
joint senior authors
Received 2020 May 31; Revised 2020 Sep 21; Accepted 2020 Oct 15; Collection date 2022 Jan 1.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC8682750 PMID: 34788418
This corrects the article "
NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss" in volume 29 on page 3691.